PLA2G4A and neurodegenerative disease: Interestingly, our in vitro results indicate that the inhibition of cPLA2 can also limit amyloid-β-induced LMP and the inhibition of autophagy [111], suggesting that similar mechanisms may also contribute to Alzheimer’s and potentially other neurodegenerative diseases.